Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -12.98%111.55B | 6.37%128.19B | -3.13%31.8B | 3.93%34.42B | 6.14%30.44B | 21.77%31.53B | 5.72%120.52B | 2.04%32.83B | 4.98%33.12B | 9.44%28.68B |
| Cost of revenue | -16.86%88.24B | 5.31%106.13B | -5.02%26.14B | 2.18%28.42B | 4.83%25.19B | 23.17%26.38B | 6.10%100.78B | 1.21%27.52B | 4.79%27.81B | 11.15%24.03B |
| Gross profit | 5.64%23.31B | 11.78%22.07B | 6.65%5.66B | 13.17%6.01B | 12.90%5.25B | 15.06%5.15B | 3.83%19.74B | 6.56%5.31B | 5.99%5.31B | 1.33%4.65B |
| Operating expense | 4.04%16.46B | 3.84%15.82B | 5.35%4.11B | 3.49%3.94B | 4.03%3.87B | 2.45%3.9B | 6.50%15.24B | 7.02%3.9B | 6.16%3.81B | 5.38%3.72B |
| Staff costs | 1.89%7.66B | 7.40%7.52B | ---- | ---- | ---- | ---- | 3.63%7B | ---- | ---- | ---- |
| Other operating expenses | 5.98%8.8B | 0.81%8.31B | ---- | ---- | ---- | ---- | 9.07%8.24B | ---- | ---- | ---- |
| Operating profit | 9.71%6.85B | 38.66%6.24B | 10.26%1.55B | 37.78%2.06B | 48.49%1.38B | 86.33%1.25B | -4.29%4.5B | 5.33%1.4B | 5.57%1.5B | -12.20%928M |
| Net non-operating interest income (expenses) | 600.00%14M | 120.00%2M | 233.33%4M | 200.00%2M | 0 | -100.00%-4M | 0.00%-10M | -200.00%-3M | 33.33%-2M | 0.00%-3M |
| Non-operating interest income | 40.91%31M | 450.00%22M | 800.00%9M | 600.00%7M | 500.00%6M | --0 | -50.00%4M | -50.00%1M | 0.00%1M | -66.67%1M |
| Non-operating interest expense | -15.00%17M | 42.86%20M | 25.00%5M | 66.67%5M | 50.00%6M | 33.33%4M | -22.22%14M | 33.33%4M | -25.00%3M | -33.33%4M |
| Net investment income | 16.83%118M | 7.45%101M | 13.51%42M | 0.00%7M | 14.29%32M | -9.09%20M | 5.62%94M | 8.82%37M | -12.50%7M | 3.70%28M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 0 | 199M | 0 | ||||||
| Income from associates and other participating interests | -216.04%-217M | -33.69%187M | 156.36%141M | -188.46%-69M | -52.70%35M | 6.67%80M | -1.40%282M | -12.70%55M | -2.50%78M | 5.71%74M |
| Special income (charges) | 124.56%42M | -3,320.00%-171M | 6M | 0.00%-1M | 98.66%-5M | |||||
| Less:Other special charges | -124.56%-42M | 3,320.00%171M | ---- | ---- | ---6M | 0.00%1M | 105.38%5M | ---- | ---- | ---- |
| Other non-operating income (expenses) | -130.23%-13M | 10.26%43M | -150.00%-3M | -83.33%2M | 162.50%21M | 76.92%23M | -48.00%39M | 110.34%6M | -88.89%12M | 8M |
| Income before tax | 6.04%6.79B | 25.58%6.41B | 4.41%1.56B | 11.79%2B | 42.04%1.47B | 75.90%1.37B | 6.94%5.1B | 41.30%1.5B | 11.32%1.79B | -5.47%1.04B |
| Income tax | 15.32%2.25B | 16.61%1.95B | -22.03%368M | 16.40%667M | 43.20%484M | 48.80%433M | 15.69%1.67B | 48.43%472M | 17.18%573M | 0.90%338M |
| Net income | 1.95%4.54B | 29.99%4.46B | 16.72%1.19B | 9.61%1.33B | 41.63%990M | 91.82%938M | 3.13%3.43B | 38.24%1.02B | 8.86%1.22B | -8.39%699M |
| Net income continuous operations | 1.98%4.54B | 29.96%4.46B | 16.62%1.19B | 9.61%1.33B | 41.49%989M | 92.02%939M | 3.13%3.43B | 38.24%1.02B | 8.76%1.22B | -8.27%699M |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to the company | 1.98%4.54B | 29.96%4.46B | 16.83%1.19B | 9.44%1.33B | 41.83%990M | 91.43%938M | 3.07%3.43B | 37.92%1.02B | 8.94%1.22B | -8.52%698M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 1.98%4.54B | 29.96%4.46B | 16.83%1.19B | 9.44%1.33B | 41.83%990M | 91.43%938M | 3.07%3.43B | 37.92%1.02B | 8.94%1.22B | -8.52%698M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 2.23%134.77 | 38.70%131.83 | 22.00%35.33 | 17.94%39.45 | 52.58%29.28 | 106.47%27.77 | 4.02%95.05 | 42.31%28.96 | 8.85%33.45 | -8.49%19.19 |
| Diluted earnings per share | 2.23%134.77 | 38.70%131.83 | 22.00%35.33 | 17.92%39.4437 | 52.68%29.28 | 106.47%27.77 | 4.02%95.05 | 42.31%28.96 | 8.90%33.45 | -8.52%19.1779 |
| Dividend per share | 35.00%54 | 14.29%40 | 15.00%23 | 0 | 13.33%17 | 0 | 0.00%35 | 0.00%20 | 0 | 0.00%15 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |